CALYPSO

Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism

EneboparatideOngoingActive not recruitingPhase 3Open NCT05778071 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

CALYPSO · Trial Tracker · ComplyRx